The Hospitalist

Significant Pathology in Young Infants Presenting with Hypothermia: A Multicenter Study

Among infants aged 90 days or younger who present to the emergency department (ED) or hospital with hypothermia, what is the ...
The Caledonian-Record

NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial

NeuraLight, the leader in developing precision neuroprogression biomarkers for neurological disease, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with ...
ascopubs.org

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine ...

Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
Medindia

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

The P hase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 ...